Cargando…

Jaw osteonecrosis management around a dental implant inserted 2 years before starting treatment with zoledronic acid

Bisphosphonates (BP) are a type of drug known to inhibit bone resorption through complex interventions. Their primary mechanism of action is aimed at the cellular level, inhibiting osteoclast activity and so bone resorption. BPs are widely used, with many patients receiving continuous treatment for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marín-Fernández, Ana-Belén, García Medina, Blas, Aguilar-Salvatierra, Antonio, Jiménez-Burkhardt, Alberto, Gómez-Moreno, Gerardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medicina Oral S.L. 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554249/ https://www.ncbi.nlm.nih.gov/pubmed/26330946 http://dx.doi.org/10.4317/jced.52234

Ejemplares similares

Dental extraction following zoledronate, induces osteonecrosis in rat´s jaw
por: Vidal-Gutiérrez, Ximena, et al.
Publicado: (2017)

Zoledronate‐Associated Osteonecrosis of the Jaw in a Dog with Appendicular Osteosarcoma
por: Lundberg, A.P., et al.
Publicado: (2016)

Medication-Related Osteonecrosis of the Jaws Initiated by Zoledronic Acid and Potential Pathophysiology
por: Alsalih, Aya, et al.
Publicado: (2021)

A Model for Osteonecrosis of the Jaw with Zoledronate Treatment following Repeated Major Trauma
por: Howie, R. Nicole, et al.
Publicado: (2015)

Bisphosphonates, vitamin D, parathyroid hormone, and osteonecrosis of the jaw. Could there be a missing link?
por: Leizaola-Cardesa, Ignacio-Osoitz, et al.
Publicado: (2016)

Platelet-Rich Plasma in Treatment of Zoledronic Acid-Induced Bisphosphonate-related Osteonecrosis of the Jaws
por: Sarkarat, Farzin, et al.
Publicado: (2014)

Denosumab/ibandronic acid/zoledronic acid: Medication-related osteonecrosis of jaw: case report
Publicado: (2021)

Geranylgeraniol Restores Zoledronic Acid-Induced Efferocytosis Inhibition in Bisphosphonate-Related Osteonecrosis of the Jaw
por: Chen, Xin, et al.
Publicado: (2021)

An Approach for the Prevention, Diagnosis, and Treatment of Jaw Osteonecrosis: Report of a Case Associated with Zoledronic Acid
por: de Alexandria Santos, Danila S., et al.
Publicado: (2020)

Treatment with teriparatide for advanced bisphosphonate-related osteonecrosis of the jaw around dental implants: a case report
por: Zushi, Yusuke, et al.
Publicado: (2017)

Bisphosphonate-related osteonecrosis of the jaw and dental implants
por: Qamheya, Ala Hassan A., et al.
Publicado: (2016)

Zoledronate treatment duration is linked to bisphosphonate‐related osteonecrosis of the jaw prevalence in rice rats with generalized periodontitis
por: Messer, Jonathan G., et al.
Publicado: (2019)

A Review Into the Effects of Pamidronic Acid and Zoledronic Acid on the Oral Mucosa in Medication-Related Osteonecrosis of the Jaw
por: Bullock, George, et al.
Publicado: (2022)

Evaluation of Jaw Osteonecrosis Following Intra-Ligament Anesthesia in Zoledronate-Treated Rats: a Histological Evaluation
por: Moradi, Saeed, et al.
Publicado: (2023)

Osteonecrosis of the Jaw
por: Lončar Brzak, Božana, et al.
Publicado: (2023)

Dental students' knowledge of medication-related osteonecrosis of the jaw
por: Rosella, Daniele, et al.
Publicado: (2017)

Denosumab and osteonecrosis of the jaw
por: Bower, Robert
Publicado: (2019)

Osteonecrosis of the jaw and denosumab
por: Goss, Alastair N
Publicado: (2022)

Associated characteristics and treatment outcomes of medication-related osteonecrosis of the jaw in patients receiving denosumab or zoledronic acid for bone metastases
por: Ikesue, Hiroaki, et al.
Publicado: (2021)

Switching from zoledronic acid to denosumab increases the risk for developing medication-related osteonecrosis of the jaw in patients with bone metastases
por: Ikesue, Hiroaki, et al.
Publicado: (2021)

THU442 A Case Of Early Medication Related Osteonecrosis Of The Jaw In Patient Receiving Intravenous Zoledronate For Treatment Of Osteoporosis
por: Ekpe, Victor, et al.
Publicado: (2023)

Correlations between Immune Response and Etiopathogenic Factors of Medication-Related Osteonecrosis of the Jaw in Cancer Patients Treated with Zoledronic Acid
por: Ciobanu, George Adrian, et al.
Publicado: (2023)

Dental practitioners' and students' knowledge of medication related osteonecrosis of the jaw (MRONJ)
por: Almousa, Mandlin Abdulaziz, et al.
Publicado: (2021)

Bisphosphonates and Their Connection to Dental Procedures: Exploring Bisphosphonate-Related Osteonecrosis of the Jaws
por: Lee, Emily Sunny, et al.
Publicado: (2023)

Aneurysmal bone cyst of the mandible affecting the articular condyle: a case report
por: Marín Fernández, Ana Belén, et al.
Publicado: (2016)

Bisphophonates related osteonecrosis of the jaw
por: Gupta, Swati, et al.
Publicado: (2013)

Is Administration of Trastuzumab an Independent Risk Factor for Developing Osteonecrosis of the Jaw Among Metastatic Breast Cancer Patients Under Zoledronic Acid Treatment?
por: Pilanci, Kezban Nur, et al.
Publicado: (2015)

Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published on Lancet Oncology
por: Fusco, Vittorio, et al.
Publicado: (2018)

Medication-related osteonecrosis of the jaws after tooth extraction in senescent female mice treated with zoledronic acid: Microtomographic, histological and immunohistochemical characterization
por: Biguetti, Claudia Cristina, et al.
Publicado: (2019)

Medication-related osteonecrosis of the jaws (MRONJ) in cancer patients treated with denosumab VS. zoledronic acid: A systematic review and meta-analysis
por: Limones, Alvaro, et al.
Publicado: (2020)

Risk evaluation of denosumab and zoledronic acid for medication-related osteonecrosis of the jaw in patients with bone metastases: a propensity score–matched analysis
por: Ikesue, Hiroaki, et al.
Publicado: (2021)

A rare case of bevacizumab-related osteonecrosis of the jaw associated with dental implants
por: Maluf, Gustavo, et al.
Publicado: (2019)

Medication-related osteonecrosis of the jaw after dental clearance: Prevalence in an oncology center
por: Hajeri, Saad, et al.
Publicado: (2022)

Medication-related osteonecrosis of the jaw using periodontitis-induced rat before tooth extraction
por: Park, Kyeong-Mee, et al.
Publicado: (2023)

Osteonecrosis of the jaw during biyearly treatment with zoledronic acid for aromatase inhibitor associated bone loss in early breast cancer: A literature review
por: Kourie, Hampig Raphael, et al.
Publicado: (2015)

Zoledronic acid increases the prevalence of medication-related osteonecrosis of the jaw in a dose dependent manner in rice rats (Oryzomys palustris) with localized periodontitis
por: Messer, J.G., et al.
Publicado: (2017)

Risk Factors for Medication-Related Osteonecrosis of the Jaw—A Binomial Analysis of Data of Cancer Patients from Craiova and Constanta Treated with Zoledronic Acid
por: Ciobanu, George Adrian, et al.
Publicado: (2023)

Osteonecrosis of jaw associated with bisphosphonate use
por: Rastogi, Ashu, et al.
Publicado: (2012)

Bisphosphonate-related osteonecrosis of the jaws (Bronj)
por: Beninati, Francesco, et al.
Publicado: (2013)

Osteonecrosis of the jaws in patients treated with bisphosphonates
por: Ata-Ali, Fadi, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_j8gdta1mqnkq52nnfnhhrrnsg6